While the US and UK sealed their BioNTech and Pfizer vaccine deals within 24 hours of the new results, the European Commission took 3 days longer to secure their larger order of 300 million doses.
Yesterday, at 6:45am in the US, the Pfizer vaccine was revealed to be over 90% effective - so when will the successful drug be available for the UK to use?
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group considers how the standard of healthcare for patients with diabetes is impacted by COVID-19.
Over 12 US Immigration and Customs Enforcement (ICE) detention centres had multiple outbreaks of infectious disease - due to withholding vaccines for adult and child migrants.
Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.
Open Access Government explores the European Commission’s Department of Health and Food Safety’s response to the COVID-19 crisis and charts their next steps towards a vaccine for every European citizen.
Professor Martin Michaelis and Dr Mark Wass, School of Biosciences at University of Kent, explain the long and infamous history of human infection trials.
Scientists from the University of Oxford, joint with AstraZeneca, are hopeful that their vaccine, to protect against Covid-19, could be available as early as September.
President von der Leyen, Council President Charles Michel and Prime Minister of Japan Shinzō Abe, discussed the global response to the COVID-19 pandemic.
